Dr. Sina Habibi reports
COGNETIVITY NEUROSCIENCES TRADES ON THE OTCQB
Cognetivity Neurosciences Ltd. has begun trading on the OTCQB in the United States under the symbol CGNSF. The company will also continue trading on the Canadian Securities Exchange.
Dr. Sina Habibi, chief executive officer and a director of Cognetivity Neurosciences, commented: "As part of our strategy to continue to increase value for our shareholders, we are very happy to announce that we have listed on the OTCQB market in the USA under the ticker symbol CGNSF. This is an important step in our public market strategy and will allow U.S. investors an easier route to getting involved in the Cognetivity story. We have a growing exposure to the U.S. market with our attendance at recent conferences and we will be taking the opportunity to grow our investor network in the largest capital markets going forwards. The USA forms an important part of our mission to help as many people as possible through our early diagnosis platform and we look forward to continuing to grow our presence there."
About Cognetivity Neurosciences Ltd.
Cognetivity Neurosciences is a technology company developing a cognitive testing platform, the integrated cognitive assessment (ICA), for use in medical and commercial environments. Cognetivity Neurosciences' ICA uses artificial intelligence and machine learning techniques to help detect the earliest signs of impairment by testing the performance of large areas of the brain, potentially allowing early diagnosis of dementia. Cognetivity Neurosciences aims to develop the ICA through planned clinical studies to the market in North America and Europe.
We seek Safe Harbor.
© 2019 Canjex Publishing Ltd. All rights reserved.